Shinji Urakami
Papers
17
Total Citations
87
H-Index
5
About
Dr. Shinji Urakami is a leading Japanese urologic oncologist whose research focuses on optimizing surgical outcomes for prostate cancer, particularly through robot-assisted radical prostatectomy (RARP). As a key member of the MSUG94 group, he has spearheaded large-scale multicenter retrospective cohort studies that have reshaped clinical decision-making. His most impactful work challenges the routine use of pelvic lymphadenectomy, demonstrating that it may not improve biochemical recurrence-free survival in Japanese patients—a finding with significant implications for reducing surgical morbidity. Dr. Urakami has also developed a nomogram to predict lymph node involvement in the RARP era, providing a practical tool for personalized treatment planning. With over 70 citations across his top papers, his research systematically addresses critical prognostic factors, including the influence of positive surgical margin locations, lymphovascular invasion, and hospital volume on oncological outcomes. His comprehensive analyses of Grade Group 4 subgroups and seminal vesicle invasion further refine risk stratification. Dr. Urakami’s work, rooted in robust Japanese cohort data, offers essential insights for urologists worldwide, bridging the gap between surgical technique and long-term cancer control.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10